Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells

Metastatic breast cancer is incurable. In order to improve patient survival, it is critical to develop a better understanding of the molecular mechanisms that regulate metastasis and the underlying process of cell motility. Here, we focus on the role of the adaptor molecule Breast Cancer Antiestrogen Resistance 3 (BCAR3) in cellular processes that contribute to cell motility, including protrusion, adhesion remodeling, and contractility. Previous work from our group showed that elevated BCAR3 protein levels enhance cell migration, while depletion of BCAR3 reduces the migratory and invasive capacities of breast cancer cells. In the current study, we show that BCAR3 is necessary for membrane protrusiveness, Rac1 activity, and adhesion disassembly in invasive breast cancer cells. We further demonstrate that, in the absence of BCAR3, RhoA-dependent signaling pathways appear to predominate, as evidenced by an increase in RhoA activity, ROCK-mediated phosphorylation of myosin light chain II, and large ROCK/mDia1-dependent focal adhesions. Taken together, these data establish that BCAR3 functions as a positive regulator of cytoskeletal remodeling and adhesion turnover in invasive breast cancer cells through its ability to influence the balance between Rac1 and RhoA signaling. Considering that BCAR3 protein levels are elevated in advanced breast cancer cell lines and enhance breast cancer cell motility, we propose that BCAR3 functions in the transition to advanced disease by triggering intracellular signaling events that are essential to the metastatic process.

[1]  Krister Wennerberg,et al.  Rho and Rac Take Center Stage , 2004, Cell.

[2]  S. Weed,et al.  Regulation of c-SRC Activity and Function by the Adapter Protein CAS , 2000, Molecular and Cellular Biology.

[3]  Margaret L. Gardel,et al.  Tension is required but not sufficient for focal adhesion maturation without a stress fiber template , 2012, The Journal of cell biology.

[4]  John Condeelis,et al.  The cofilin pathway in breast cancer invasion and metastasis , 2007, Nature Reviews Cancer.

[5]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[6]  R. Riggins,et al.  Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. , 2007, Cancer research.

[7]  G. Mostoslavsky,et al.  BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas. , 2011, Cellular signalling.

[8]  R. Birge,et al.  C‐terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac‐GEF , 2005, Journal of cellular physiology.

[9]  A. Bouton,et al.  Detection of distinct pools of the adapter protein p130CAS using a panel of monoclonal antibodies. , 1997, Hybridoma.

[10]  R. Klemke,et al.  Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold , 2002, The Journal of cell biology.

[11]  E. Pasquale,et al.  NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling , 2011, Nature Structural &Molecular Biology.

[12]  Richard Superfine,et al.  The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins , 2011, Nature Cell Biology.

[13]  T. Freddo,et al.  Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens , 2009, Molecular vision.

[14]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[15]  P. Defilippi,et al.  Integrin signalling adaptors: not only figurants in the cancer story , 2010, Nature Reviews Cancer.

[16]  Gerald R. Fink,et al.  Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex , 2002, Nature Cell Biology.

[17]  Stephan Huveneers,et al.  Adhesion signaling – crosstalk between integrins, Src and Rho , 2009, Journal of Cell Science.

[18]  K. Burridge,et al.  Rho protein crosstalk: another social network? , 2011, Trends in cell biology.

[19]  Martin A. Schwartz,et al.  Cell adhesion: integrating cytoskeletal dynamics and cellular tension , 2010, Nature Reviews Molecular Cell Biology.

[20]  R. Near,et al.  Breast Cancer Anti-estrogen Resistance 3 (BCAR3) Protein Augments Binding of the c-Src SH3 Domain to Crk-associated Substrate (p130cas)* , 2012, The Journal of Biological Chemistry.

[21]  A. Ridley,et al.  Rho GTPases in cancer cell biology , 2008, FEBS letters.

[22]  R. Near,et al.  AND‐34/BCAR3 differs from other NSP homologs in induction of anti‐estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology , 2007, Journal of cellular physiology.

[23]  Robert L. Sutherland,et al.  Biological determinants of endocrine resistance in breast cancer , 2009, Nature Reviews Cancer.

[24]  Miguel Vicente-Manzanares,et al.  Actin and α-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner , 2008, Nature Cell Biology.

[25]  A. Smolyar,et al.  AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. , 1999, Journal of immunology.

[26]  C. Albanese,et al.  AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. , 2003, Cancer research.

[27]  M. Clynes,et al.  Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[29]  R. Finn,et al.  Targeting Src in breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  J. Parsons,et al.  Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. , 2012, Genes & cancer.

[31]  Gaudenz Danuser,et al.  Coordination of Rho GTPase activities during cell protrusion , 2009, Nature.

[32]  R. Riggins,et al.  Pathways to tamoxifen resistance. , 2007, Cancer letters.

[33]  J. Settleman,et al.  c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation , 1995, The Journal of cell biology.

[34]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.

[35]  Rebecca B. Riggins,et al.  Synergistic Promotion of c-Src Activation and Cell Migration by Cas and AND-34/BCAR3* , 2003, Journal of Biological Chemistry.

[36]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[37]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[38]  S. Narumiya,et al.  Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion , 2009, Cancer and Metastasis Reviews.

[39]  J. Foekens,et al.  Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment. , 2000, Journal of the National Cancer Institute.

[40]  L. Carey,et al.  Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.

[41]  S. Parsons,et al.  c-Src, receptor tyrosine kinases, and human cancer. , 1999, Advances in cancer research.

[42]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[43]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[44]  R. Schrecengost,et al.  BCAR3 Regulates Src/p130Cas Association, Src Kinase Activity, and Breast Cancer Adhesion Signaling* , 2009, The Journal of Biological Chemistry.

[45]  Robert Clarke,et al.  Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. , 2006, Cancer research.

[46]  E. Pasquale,et al.  Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling. , 2007, Gene.

[47]  K. Vuori,et al.  CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration , 1998, The Journal of cell biology.

[48]  C. Lim,et al.  Protein Tyrosine Phosphatase α Phosphotyrosyl-789 Binds BCAR3 To Position Cas for Activation at Integrin-Mediated Focal Adhesions , 2012, Molecular and Cellular Biology.